SCALE Diabetes

What is SCALE Diabetes?

Liraglutide 3.0 mg tested in adults who had both obesity and type 2 diabetes (Davies et al., JAMA 2015): −6.0% body weight at 56 weeks against −2.0% on placebo.

It established the indication Saxenda still serves.

Related reading: SCALE Diabetes: Liraglutide With Type 2 Diabetes

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where SCALE Diabetes comes up on this site

Other terms under trial

• SURMOUNT-5
• SURMOUNT-2
• SURMOUNT-3
• SURPASS-2
• SUSTAIN-6
• REWIND
• PIONEER 6
• STEP-HFpEF
• EXSCEL
• ELIXA
• AMPLITUDE-O
• HARMONY OUTCOMES
• STEP 2
• SUMMIT
• SCALE Maintenance

Where the evidence lives

• The full GLP-1 glossary (150 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers